Cytotoxic Drugs Market
Market Insights on Cytotoxic Drugs covering sales outlook, demand forecast & up-to-date key trends
Cytotoxic Drugs Market by Product Type (Branded Drugs, Generic Drugs), Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, Others), Route of Administration (Oral, Parenteral), End User (Hospitals, Cancer Research Centres, Drug Testing Laboratories, CDMOs) & Region - Forecast 2022 - 2028
Cytotoxic Drugs Market Outlook (2022-2028)
[338 Pages Report] The global Cytotoxic Drugs Market is expected to account for a valuation of US$ 16.2 Bn in 2022, and rise at a sluggish CAGR of 0.9% to reach an estimated net worth of US$ 17.1 Bn by the end of 2028.
|
Cytotoxic Drugs Market Size (2022) |
US$ 16.2 Bn |
|
Revenue Forecast (2028) |
US$ 17.1 Bn (2028) |
|
Global Market Growth Rate (2022-2028) |
0.9% CAGR |
|
Regional Market With Largest Share |
North America – 41.8% |
|
Top 5 Cytotoxic Medication Manufacturers |
Johnson and Johnson, Pfizer, Teva Pharmaceutical, Mylan NV, Fresenius Kabi AG |
Classification of cytotoxic drugs as per alkylating agents, antitumor antibiotics, antimetabolites, etc., has been studied in this cytotoxic drugs research report by Future Market Insights (FMI). Cytotoxic drugs are also known as antineoplastic drugs.
Sales of cytotoxic drugs account for around 13.4% share of the global oncology drugs and therapeutics market. Cytotoxic drug side effects are well known and have restrained the market from reaching its optimal revenue potential
Let us know your requirement to get
100% FREE customization
Consumption Analysis of Cytotoxic Drugs (2013 to 2021) Vs Market Estimates (2022 to 2028)
The world has seen a substantial rise in the use of drugs for medical treatment as the prevalence of chronic diseases has increased. Instances of cancer have risen substantially across the globe, and this has increased demand for cancer drugs and cancer therapies for its treatment. Cytotoxic drugs are the first choice and first line of defence in the treatment of cancer via chemotherapy.
The cytotoxic drugs market saw expansion at a CAGR of 1% from 2013 to 2021, and held a net worth of US$ 16 Bn in 2021.
Sales of cytotoxic medicines have seen a rise over the past decade but the growth is expected to slow down as new treatment methods are popularized. The cytotoxic drug side effects are one of the major factors that restrain their sales and usage. The potential damage caused by exposure to cytotoxic drugs has led to skepticism around their usage. Some of the side effects include nausea, dizziness, hair loss, infection, constipation, etc.
On the basis of classification, cytotoxic drugs can be used for multiple cancer treatment applications. Cytotoxic drug classification by alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others is detailed in this cytotoxic drugs market survey. Demand for cytotoxic drugs is anticipated to rise at a sluggish CAGR of 0.9% from 2022 to 2028.
How is the Cytotoxic Drugs Industry Expected to Perform across Major Regions?
This global cytotoxic medication industry analysis provides detailed insights across multiple geographies such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
The North American cytotoxic drug products market is expected to hold a dominant global market share of 41.8% and is anticipated to keep this up over the forecast period as well. Rising cancer awareness and increasing research & development by prominent cytotoxic drug manufacturers are some major factors driving the market growth in this region.
Demand for cytotoxic drugs is expected to rise rapidly in East Asia, South Asia, and the Pacific, and collectively, these regions would hold a market share of 21.5% on a global scale in 2022. Cytotoxic drugs consumption in these regions are expected to be driven by aspects such as rising demand for multiple cancer drugs, increasing awareness, government initiatives that are backing the research & development of antineoplastic drugs, etc.
The cytotoxic medicines market in Europe is predicted to hold around 28.1% share of the global marketplace in 2022. Increasing incidence of cancer in the region are expected to majorly influence the sales of cytotoxic drugs.
Cytotoxic drugs demand in the MEA region is expected to see a steady rise over the forecast period as the healthcare infrastructure in this region develops and awareness about cancer rises.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Analysis
How are Sales of Cytotoxic Drugs Expected to Shape Up in the U.S.?
The U.S. cytotoxic drugs market is one with high potential, and this is due to the high prevalence of multiple cancer cases in the nation. The U.S. has seen a huge rise in cancer cases in the past couple of decades, which can be attributed to decreasing quality of lifestyle, rising prevalence of obesity, etc.
Demand for cytotoxic drugs in the U.S. is expected to be driven by increasing cancer awareness and rising geriatric population in the nation. Its developed and advanced healthcare infrastructure creates a lucrative setting for the sales of cytotoxic drugs in the U.S.
Why Should Cytotoxic Drugs Producers Focus on India?
India has seen a rise in the number of cancer instances over the past few years, and there has also been an increase in awareness about the disease and its treatment. The nation has a massive population and a rapidly developing healthcare infrastructure that promotes demand for cytotoxic drugs as awareness for the treatment of cancer increases.
India is also a favourable market for cytotoxic drugs manufacturers as it provides low manufacturing costs and favourable regulations, which make drug approvals fairly easy in comparison to other nations.
Cytotoxic Drugs Market - Category-wise Analysis
Which End User Accounts for Majority Sales of Antineoplastic Drugs?
Use of cytotoxic drugs is usually the first aspect of cancer treatments and is one of the much-known cancer treatment methods. Most injectable cytotoxic drugs are administered by healthcare professionals since it is required to do it in a safe manner and improper administration could lead to harmful cytotoxic drugs side effects which can be as severe as damage to chromosomes when in direct contact with an individual.
Hence, majority of demand for antineoplastic drugs is driven by hospitals.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
COVID-19 Impact Analysis
In 2020, when coronavirus infections surged globally, the world saw some major changes that were never expected by anyone. As infections spread across the world, in an effort to contain the spread lockdowns were imposed on a global scale and the world came to a halt like never before. This drastically affected multiple markets and most markets toppled under the sudden change and lockdown restrictions which ceased operations to a drastic extent.
The healthcare industry was the only industry that benefited from the pandemic along with some other industry verticals. The cytotoxic drugs space was one of the few markets that did not see a negative impact of the COVID-19 pandemic and managed to get through the pandemic phase with relative ease than most markets.
Demand for cytotoxic drugs saw a rise and is expected to show a positive outlook over the post-pandemic era as well citing the prevalence of different types of cancers.
Cytotoxic Drugs Market - Competitive Landscape
Cytotoxic drug manufacturers are focusing on mergers and collaborations to increase their research scope to develop new drugs that cater to most cancers and meet regulations of multiple countries. Cytotoxic drug companies are also focusing on increasing awareness about the use of antineoplastic drugs to treat cancer.
- In May 2021, Zydus Cadila a pharmaceutical subsidiary of Zydus group, announced the launch of its new drug for breast cancer treatment in India. Trastuzumab Emtansine is said to be the first targeted chemotherapy drug for breast cancer that is capable of directing cytotoxic activity towards cancer cells with the use of a biomarker.
- In October 2021, NanoString Technologies Inc., a major name in the life science tools industry, announced the launch of a new gene expression tool that would aid in the rapid expansion of the Antibody Drug Conjugates (ADCs) field. This new nCounter® ADC Development Panel would aid in developing drugs that can differentiate healthy and cancer tissues with cytotoxic drug’s cell-killing abilities, and hence reduce the side effects on healthy tissues and cells.
Cytotoxic Drugs Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Cytotoxic Drugs Industry Survey
Cytotoxic Drugs Market by Product Type:
- Branded Drugs
- Generic Drugs
Cytotoxic Drugs Market by End User:
- Hospitals
- Cancer Research Centres
- Drug Testing Laboratories
- CDMOs
Cytotoxic Drugs Market by Route of Administration:
- Oral Cytotoxic Drugs
- Parenteral Cytotoxic Drugs
Cytotoxic Drugs Market by Drug Type:
- Alkylating Agents
- Antitumor Antibiotics
- Antimetabolites
- Plant Alkaloids
- Others
Cytotoxic Drugs Market by Region:
- North America Cytotoxic Drugs Market
- Latin America Cytotoxic Drugs Market
- Europe Cytotoxic Drugs Market
- East Asia Cytotoxic Drugs Market
- South Asia & Pacific Cytotoxic Drugs Market
- Middle East & Africa (MEA) Cytotoxic Drugs Market
Frequently Asked Questions
Cytotoxic drugs contain chemicals that are toxic to cells, thereby preventing their replication.
The global cytotoxic drugs market is predicted to be valued at US$ 16.2 Bn in 2022.
The North American cytotoxic drugs market holds a dominant market share of 41.8% in the global landscape.
As per FMI analysis, the cytotoxic drugs market is set to progress at a CAGR of 0.9% over the forecast period of 2022 to 2028.
CytoPharma, Bristol-Myers Squibb, Amgen Inc., Celgene Corp., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson and Johnson, Lonza, and Merck & Co. Inc. are major producers of cytotoxic drugs.
The cytotoxic drugs market is projected to attain a revenue of US$ 17.1 Bn by 2028.
1. Executive Summary
A gist of the report, highlighting the key takeaways
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction A definition of Cytotoxic Drugs Market and related market taxonomy
2.1. Market Taxonomy
2.2. Market Definition
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
3.2. Macroeconomic Assumptions
3.3. Global Economic Outlook
4. Market Overview
4.1. Market Outlook
4.2. Key Inclusions
4.2.1. Pipeline analysis
4.2.2. Regulations
4.2.3. Toxicity Classification (SafeBridge)
4.2.4. Outlook on cytotoxic requirements in drug conjugation
4.2.5. Standards for the safe handling of cytotoxic drugs
4.2.6. Snapshot Of Cancer Cases
5. North America Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028 Market forecast and analysis in the U.S. and Canada
5.1. Introduction
5.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
5.2.1. U.S.
5.2.2. Canada
5.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
5.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
5.4.1. Alkylating Agents
5.4.2. Antitumor Antibiotics
5.4.3. Antimetabolites
5.4.4. Plant Alkaloids
5.4.5. Others
5.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
5.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
5.6.1. Oral
5.6.2. Parenteral
5.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
5.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
5.8.1. Branded Drugs
5.8.2. Generic Drugs
5.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
5.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
5.10.1. Hospital
5.10.2. Cancer Research Center
5.10.3. Drug Testing Laboratory
5.10.4. CDMOs
5.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
5.12. Market Attractiveness Analysis
5.12.1. By Country
5.12.2. By Drug Type
5.12.3. By Route Of Administration
5.12.4. By Product Type
5.12.5. By End User
5.13. Key Market Participants – Intensity Mapping
5.14. Drivers and Restraints – Impact Analysis
6. Western Europe Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in the Western European Countries
6.1. Introduction
6.2. Historical Market Size (US$ Mn) By Country, 2013–2021
6.2.1. Germany
6.2.2. France
6.2.3. U.K.
6.2.4. Spain
6.2.5. Italy
6.2.6. BENELUX
6.2.7. Nordics
6.2.8. Rest of Western Europe
6.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
6.4.1. Alkylating Agents
6.4.2. Antitumor Antibiotics
6.4.3. Antimetabolites
6.4.4. Plant Alkaloids
6.4.5. Others
6.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
6.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
6.6.1. Oral
6.6.2. Parenteral
6.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
6.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
6.8.1. Branded Drugs
6.8.2. Generic Drugs
6.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
6.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
6.10.1. Hospital
6.10.2. Cancer Research Center
6.10.3. Drug Testing Laboratory
6.10.4. CDMOs
6.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
6.12. Market Attractiveness Analysis
6.12.1. By Country
6.12.2. By Drug Type
6.12.3. By Route Of Administration
6.12.4. By Product Type
6.12.5. By End User
6.13. Key Market Participants – Intensity Mapping
6.14. Drivers and Restraints – Impact Analysis
7. Eastern Europe Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in the Eastern European countries
7.1. Introduction
7.2. Historical Market Size (US$ Mn) By Country, 2013–2021
7.2.1. Russia
7.2.2. Poland
7.2.3. Rest of Eastern Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
7.4.1. Alkylating Agents
7.4.2. Antitumor Antibiotics
7.4.3. Antimetabolites
7.4.4. Plant Alkaloids
7.4.5. Others
7.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
7.6.1. Oral
7.6.2. Parenteral
7.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
7.8.1. Branded Drugs
7.8.2. Generic Drugs
7.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
7.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
7.10.1. Hospital
7.10.2. Cancer Research Center
7.10.3. Drug Testing Laboratory
7.10.4. CDMOs
7.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Drug Type
7.12.3. By Route Of Administration
7.12.4. By Product Type
7.12.5. By End User
7.13. Key Market Participants – Intensity Mapping
7.14. Drivers and Restraints – Impact Analysis
8. Latin America Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in Latin American countries
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Country, 2013–2021
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
8.4.1. Alkylating Agents
8.4.2. Antitumor Antibiotics
8.4.3. Antimetabolites
8.4.4. Plant Alkaloids
8.4.5. Others
8.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
8.6.1. Oral
8.6.2. Parenteral
8.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
8.8.1. Branded Drugs
8.8.2. Generic Drugs
8.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
8.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
8.10.1. Hospital
8.10.2. Cancer Research Center
8.10.3. Drug Testing Laboratory
8.10.4. CDMOs
8.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Drug Type
8.12.3. By Route Of Administration
8.12.4. By Product Type
8.12.5. By End User
8.13. Key Market Participants – Intensity Mapping
8.14. Drivers and Restraints – Impact Analysis
9. Asia Pacific excluding Japan and China (APEJC) Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in the Asia Pacific countries excluding China and Japan
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By Country, 2013–2021
9.2.1. India
9.2.2. Australia and New Zealand
9.2.3. ASEAN
9.2.4. Rest of APEJ
9.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
9.4.1. Alkylating Agents
9.4.2. Antitumor Antibiotics
9.4.3. Antimetabolites
9.4.4. Plant Alkaloids
9.4.5. Others
9.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
9.6.1. Oral
9.6.2. Parenteral
9.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
9.8.1. Branded Drugs
9.8.2. Generic Drugs
9.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
9.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
9.10.1. Hospital
9.10.2. Cancer Research Center
9.10.3. Drug Testing Laboratory
9.10.4. CDMOs
9.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Drug Type
9.12.3. By Route Of Administration
9.12.4. By Product Type
9.12.5. By End User
9.13. Key Market Participants – Intensity Mapping
9.14. Drivers and Restraints – Impact Analysis
10. Japan Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in Japan
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
10.2.1. Alkylating Agents
10.2.2. Antitumor Antibiotics
10.2.3. Antimetabolites
10.2.4. Plant Alkaloids
10.2.5. Others
10.3. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
10.4.1. Oral
10.4.2. Parenteral
10.5. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
10.6.1. Branded Drugs
10.6.2. Generic Drugs
10.7. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
10.8.1. Hospital
10.8.2. Cancer Research Center
10.8.3. Drug Testing Laboratory
10.8.4. CDMOs
10.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
10.10. Market Attractiveness Analysis
10.10.1. By Drug Type
10.10.2. By Route Of Administration
10.10.3. By Product Type
10.10.4. By End User
10.11. Key Market Participants – Intensity Mapping
10.12. Drivers and Restraints – Impact Analysis
11. China Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in China
11.1. Introduction
11.1. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
11.1.1. Alkylating Agents
11.1.2. Antitumor Antibiotics
11.1.3. Antimetabolites
11.1.4. Plant Alkaloids
11.1.5. Others
11.2. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
11.3. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
11.3.1. Oral
11.3.2. Parenteral
11.4. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
11.5.1. Branded Drugs
11.5.2. Generic Drugs
11.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
11.7.1. Hospital
11.7.2. Cancer Research Center
11.7.3. Drug Testing Laboratory
11.7.4. CDMOs
11.8. Market Size (US$ Mn) Forecast By End User, 2022–2028
11.9. Market Attractiveness Analysis
11.9.1. By Drug Type
11.9.2. By Route Of Administration
11.9.3. By Product Type
11.9.4. By End User
11.10. Key Market Participants – Intensity Mapping
11.11. Drivers and Restraints – Impact Analysis
12. MEA Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
Market forecast and analysis in MEA countries focusing on GCC and South Africa
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Country, 2013–2021
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
12.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2021
12.4.1. Alkylating Agents
12.4.2. Antitumor Antibiotics
12.4.3. Antimetabolites
12.4.4. Plant Alkaloids
12.4.5. Others
12.5. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
12.6.1. Oral
12.6.2. Parenteral
12.7. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
12.8. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
12.8.1. Branded Drugs
12.8.2. Generic Drugs
12.9. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
12.10. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
12.10.1. Hospital
12.10.2. Cancer Research Center
12.10.3. Drug Testing Laboratory
12.10.4. CDMOs
12.11. Market Size (US$ Mn) Forecast By End User, 2022–2028
12.12. Market Attractiveness Analysis
12.12.1. By Country
12.12.2. By Drug Type
12.12.3. By Route Of Administration
12.12.4. By Product Type
12.12.5. By End User
12.13. Participants – Intensity Mapping
12.14. Drivers and Restraints – Impact Analysis
13. Forecast Factors: Relevance and Impact
14. Competition Analysis
14.1. Competition Dashboard
14.2. Company Deep Dive
14.2.1. CytoPharma
14.2.1.1. Overview
14.2.1.2. Product and Application Portfolio
14.2.1.3. Channel Footprint
14.2.1.4. Strategy
14.2.1.4.1. Marketing Strategy
14.2.1.4.2. Product Strategy
14.2.1.4.3. Channel Strategy
14.2.2. Bristol-Myers Squibb
14.2.2.1. Overview
14.2.2.2. Product and Application Portfolio
14.2.2.3. Channel Footprint
14.2.2.4. Strategy
14.2.2.4.1. Marketing Strategy
14.2.2.4.2. Product Strategy
14.2.2.4.3. Channel Strategy
14.2.3. Amgen Inc.
14.2.3.1. Overview
14.2.3.2. Product and Application Portfolio
14.2.3.3. Channel Footprint
14.2.3.4. Strategy
14.2.3.4.1. Marketing Strategy
14.2.3.4.2. Product Strategy
14.2.3.4.3. Channel Strategy
14.2.4. Celgene Corp.
14.2.4.1. Overview
14.2.4.2. Product and Application Portfolio
14.2.4.3. Channel Footprint
14.2.4.4. Strategy
14.2.4.4.1. Marketing Strategy
14.2.4.4.2. Product Strategy
14.2.4.4.3. Channel Strategy
14.2.4.4.3.1.
14.2.5. Eli Lilly and Company
14.2.5.1. Overview
14.2.5.2. Product and Application Portfolio
14.2.5.3. Channel Footprint
14.2.5.4. Strategy
14.2.5.4.1. Marketing Strategy
14.2.5.4.2. Product Strategy
14.2.5.4.3. Channel Strategy
14.2.6. F. Hoffmann-La Roche AG
14.2.6.1. Overview
14.2.6.2. Product and Application Portfolio
14.2.6.3. Channel Footprint
14.2.6.4. Strategy
14.2.6.4.1. Marketing Strategy
14.2.6.4.2. Product Strategy
14.2.6.4.3. Channel Strategy
14.2.7. GlaxoSmithKline PLC
14.2.7.1. Overview
14.2.7.2. Product and Application Portfolio
14.2.7.3. Channel Footprint
14.2.7.4. Strategy
14.2.7.4.1. Marketing Strategy
14.2.7.4.2. Product Strategy
14.2.7.4.3. Channel Strategy
14.2.8. Johnson and Johnson
14.2.8.1. Overview
14.2.8.2. Product and Application Portfolio
14.2.8.3. Channel Footprint
14.2.8.4. Strategy
14.2.8.4.1. Marketing Strategy
14.2.8.4.2. Product Strategy
14.2.8.4.3. Channel Strategy
14.2.9. Lonza
14.2.9.1. Overview
14.2.9.2. Product and Application Portfolio
14.2.9.3. Channel Footprint
14.2.9.4. Strategy
14.2.9.4.1. Marketing Strategy
14.2.9.4.2. Product Strategy
14.2.9.4.3. Channel Strategy
14.2.10. Merck & Co., Inc.
14.2.10.1. Overview
14.2.10.2. Product and Application Portfolio
14.2.10.3. Channel Footprint
14.2.10.4. Strategy
14.2.10.4.1. Marketing Strategy
14.2.10.4.2. Product Strategy
14.2.10.4.3. Channel Strategy
14.2.11. Novartis AG
14.2.11.1. Overview
14.2.11.2. Product and Application Portfolio
14.2.11.3. Channel Footprint
14.2.11.4. Strategy
14.2.11.4.1. Marketing Strategy
14.2.11.4.2. Product Strategy
14.2.11.4.3. Channel Strategy
14.2.12. Pfizer
14.2.12.1. Overview
14.2.12.2. Product and Application Portfolio
14.2.12.3. Channel Footprint
14.2.12.4. Strategy
14.2.12.4.1. Marketing Strategy
14.2.12.4.2. Product Strategy
14.2.12.4.3. Channel Strategy
14.2.13. Sanofi
14.2.13.1. Overview
14.2.13.2. Product and Application Portfolio
14.2.13.3. Channel Footprint
14.2.13.4. Strategy
14.2.13.4.1. Marketing Strategy
14.2.13.4.2. Product Strategy
14.2.13.4.3. Channel Strategy
14.2.14. Teva Pharmaceutical
14.2.14.1. Overview
14.2.14.2. Product and Application Portfolio
14.2.14.3. Channel Footprint
14.2.14.4. Strategy
14.2.14.4.1. Marketing Strategy
14.2.14.4.2. Product Strategy
14.2.14.4.3. Channel Strategy
15. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Region
A detailed, region-wise assessment, providing projections on market growth in key regions
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2021
15.2.1. North America
15.2.2. Western Europe
15.2.3. Eastern Europe
15.2.4. Latin America
15.2.5. Asia Pacific excluding Japan and China
15.2.6. Japan
15.2.7. China
15.2.8. Middle East and Africa
15.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
15.4. Market Attractiveness Analysis By Region
16. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Drug Type
Classification of Cytotoxic Drugs Market by Drug Type; highlighting historical trends, current market value, and future projections on the basis of key segments
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Type, 2013–2021
16.2.1. Alkylating Agents
16.2.2. Antitumor Antibiotics
16.2.3. Antimetabolites
16.2.4. Plant Alkaloids
16.2.5. Others
16.3. Market Size (US$ Mn) Forecast By Drug Type, 2022–2028
16.4. Market Attractiveness Analysis By Drug Type
17. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Route Of Administration
Classification of Cytotoxic Drugs Market by Route Of Administration; highlighting historical trends, current market value, and future projections on the basis of key segments
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2013–2021
17.2.1. Clinical Batch Production
17.2.2. Commercial Production
17.3. Market Size (US$ Mn) Forecast By Route Of Administration, 2022–2028
17.4. Market Attractiveness Analysis By Route Of Administration
18. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By Product Type
Assessment of Product Type which is currently gaining traction, along with projections on how demand will shape up in the future
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
18.2.1. Branded Drugs
18.2.2. Generic Drugs
18.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
18.4. Market Attractiveness Analysis By Product Type
19. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028, By End User
Assessment of end user segments currently gaining traction, along with projections on how demand will shape up in the future
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
19.2.1. Hospital
19.2.2. Cancer Research Center
19.2.3. Drug Testing Laboratory
19.2.4. CDMOs
19.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
19.4. Market Attractiveness Analysis By End User
20. Global Cytotoxic Drugs Market Analysis 2013–2021 and Forecast 2022–2028
20.1. Market Value Share Analysis
20.1.1. By Country
20.1.2. By Drug Type
20.1.3. By Route Of Administration
20.1.4. By Product Type
20.1.5. By End User
20.2. Y-o-Y Growth Analysis
20.2.1. By Country
20.2.2. By Drug Type
20.2.3. By Route Of Administration
20.2.4. By Product Type
20.2.5. By End User
20.3. Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 2: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 3: Ongoing clinical trials for cytotoxic drugs
Table 4: Cytotoxic Drugs in Markets Across The World
Table 5: Cytotoxic Agents and Specific Target
Table 6: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 7: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 8: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 9: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 10: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 11: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 12: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 13: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 14: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 15: Latin America Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 16: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 17: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 18: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 19: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 20: Western Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 21: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 22: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 23: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 24: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 25: Eastern Europe Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 26: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 27: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 28: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 29: China Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 30: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 31: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 32: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 33: Japan Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 34: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 35: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 36: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 37: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 38: APECJ Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 39: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 40: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 41: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 42: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 43: MEA Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Table 44: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region
Table 45: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Type
Table 46: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route Of Administration
Table 47: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 48: Global Cytotoxic Drugs Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Clinical trials of cytotoxics as reported, by Phase
Figure 2: Number of clinical trials of cytotoxics, by Completion date ( 1993-2045)
Figure 3: North America Cytotoxic Drugs Market Value Share by Drug Type, 2022
Figure 4: North America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2022 & 2028
Figure 5: North America Cytotoxic Drugs Market Attractiveness Index by Country, 2022 – 2028
Figure 6: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021
Figure 7: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028
Figure 8: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By U.S.
Figure 9: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By U.S.
Figure 10: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Canada
Figure 11: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Canada
Figure 12: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Alkylating drugs
Figure 13: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Alkylating drugs
Figure 14: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Antimetabolites
Figure 15: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Antimetabolites
Figure 16: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, ByforPlant Alkaloids
Figure 17: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Plant Alkaloids
Figure 18: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Antitumor Antibiotics
Figure 19: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Antitumor Antibiotics
Figure 20: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Others
Figure 21: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2021–2028, By Others
Figure 22: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Oral
Figure 23: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Oral
Figure 24: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Parenteral
Figure 25: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Parenteral
Figure 26: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Branded Drugs
Figure 27: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Branded Drugs
Figure 28: North America Cytotoxic Drugs Market Size (US$ Mn) Analysis, 2013–2021, By Generic Drugs
Figure 29: North America Cytotoxic Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2028, By Generic Drugs
Figure 30: North America Cytotoxic Drugs Market Attractiveness Analysis, By Drug Type
Figure 31: North America Cytotoxic Drugs Market Attractiveness Analysis, By Route Of Administration
Figure 32: North America Cytotoxic Drugs Market Attractiveness Analysis, By Product Type
Figure 33: North America Cytotoxic Drugs Market Attractiveness Analysis, By End User
Figure 34: Latin America Cytotoxic Drugs Market Value Share by Drug Type, 2022
Figure 35: Latin America Cytotoxic Drugs Market, BPS Analysis by Country – 2013, 2022 & 2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
